KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Revenue (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Revenue for 9 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Revenue rose 12.16% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 billion through Dec 2025, up 6.22% year-over-year, with the annual reading at $4.7 billion for FY2025, 6.22% up from the prior year.
  • Revenue hit $1.1 billion in Q4 2025 for Elanco Animal Health, up from $1.1 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.3 billion in Q2 2021 to a low of $985.0 million in Q4 2022.
  • Historically, Revenue has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2025.
  • Biggest five-year swings in Revenue: skyrocketed 118.09% in 2021 and later fell 11.42% in 2022.
  • Year by year, Revenue stood at $1.1 billion in 2021, then fell by 11.42% to $985.0 million in 2022, then increased by 5.08% to $1.0 billion in 2023, then dropped by 1.45% to $1.0 billion in 2024, then increased by 12.16% to $1.1 billion in 2025.
  • Business Quant data shows Revenue for ELAN at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.2 billion in Q2 2025.